Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Q2 2025: A recap of the top headlines and interviews
View our Q2 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.
Food Insecurity and the Dangers of Infant Formula Dilution
Study: Idiopathic central precocious puberty patients at increased risk for psychiatric disorders
Data from the study suggest caretakers of CPP patients be vigilant for psychiatric symptoms to begin care at an early stage.
Demystifying Infant Formula
FDA revises labeling on extended-release stimulants for ADHD to include weight loss risk
The revised labeling will warn that patients younger than 6 years taking these medications are at greater risk of weight loss.
FDA news in pediatrics: June 2025
A look back at the FDA submissions and regulatory decisions in the pediatric health care space from June 2025.